Cytosorbents ROCE 2024

Cytosorbents Aktienanalyse

What does Cytosorbents do?

Cytosorbents Corp is a US-American company specialized in the development of medical technologies for the treatment of life-threatening diseases and injuries. It was founded in 1997 by Dr. Phillip Chan. Originally, Cytosorbents specialized in the development of therapeutics for cancer therapy. After several development phases and a realignment of the company, they eventually focused on developing medical products for intensive care medicine. The business model of Cytosorbents is based on the development and marketing of blood purification systems that remove harmful substances and toxins from the blood. This can treat life-threatening diseases and complications such as sepsis, organ failure, or severe burns. An important product of Cytosorbents is the Cytosorb system, which consists of an extracorporeal blood purification device. The system is used to attenuate disease-related inflammatory reactions and remove harmful substances from the blood. This is intended to prevent complications and improve the survival of patients. Cytosorbents offers the Cytosorb system, among other things, for use in intensive and emergency medicine. It is used, among other things, to treat sepsis, which can lead to life-threatening organ failure. It is also used to treat severe burns, to rid the blood of toxic substances and inflammatory mediators, and thus accelerate the healing process. In addition to the Cytosorb system, the company also offers other medical products such as the HemoDefend plasma exchanger. This system is used to purify blood plasma from harmful substances while retaining the beneficial components in the plasma. It is used, among other things, to treat patients in need of a blood transfusion. Cytosorbents has experienced significant expansion in recent years. The company has established subsidiaries in Europe, Asia, and the Middle East and works closely with major hospitals and medical facilities. Additionally, the company has formed several partnerships with leading medical technology companies to expand the use of its technology in other areas. In summary, Cytosorbents is an innovative company specializing in the development of medical devices for the treatment of life-threatening diseases. The company has expanded significantly in recent years and collaborates with renowned hospitals and medical facilities. In the future, Cytosorbents will continue to refine and improve its technologies to help even more patients. Cytosorbents ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cytosorbents's Return on Capital Employed (ROCE)

Cytosorbents's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cytosorbents's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cytosorbents's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cytosorbents’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cytosorbents stock

What is the ROCE (Return on Capital Employed) of Cytosorbents this year?

The ROCE of Cytosorbents is -1.3 undefined this year.

How has the ROCE (Return on Capital Employed) of Cytosorbents developed compared to the previous year?

The ROCE of Cytosorbents has increased by 45.95% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cytosorbents?

A high Return on Capital Employed (ROCE) indicates that Cytosorbents has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cytosorbents?

A low ROCE (Return on Capital Employed) can indicate that Cytosorbents has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cytosorbents impact the company?

An increase in the ROCE of Cytosorbents can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cytosorbents affect the company?

A decrease in ROCE of Cytosorbents can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cytosorbents?

Some factors that can affect Cytosorbents's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cytosorbents so important for investors?

The ROCE of Cytosorbents is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cytosorbents take to improve the ROCE?

To improve the ROCE, Cytosorbents can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cytosorbents pay?

Over the past 12 months, Cytosorbents paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cytosorbents is expected to pay a dividend of 0 USD.

What is the dividend yield of Cytosorbents?

The current dividend yield of Cytosorbents is .

When does Cytosorbents pay dividends?

Cytosorbents pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cytosorbents?

Cytosorbents paid dividends every year for the past 0 years.

What is the dividend of Cytosorbents?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cytosorbents located?

Cytosorbents is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cytosorbents kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cytosorbents from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did Cytosorbents pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of Cytosorbents in the year 2023?

In the year 2023, Cytosorbents distributed 0 USD as dividends.

In which currency does Cytosorbents pay out the dividend?

The dividends of Cytosorbents are distributed in USD.